Literature DB >> 9935204

The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.

C M Magnusson1, I R Persson, J A Baron, A Ekbom, R Bergström, H O Adami.   

Abstract

It is unclear whether age at menarche is causally involved in breast-cancer aetiology, or serves a correlate of other early-life exposures. Other aspects of reproductive life, including cycle length and regularity, climacteric symptoms, reproductive history and oral contraceptive use, are also incompletely investigated. We examined these issues in a population-based case-control study, including 3,016 women aged 50 to 74 years with invasive breast cancer, and 3,263 controls of similar age. Mailed questionnaires and telephone interviews were used to collect information on menstrual and reproductive characteristics as well as use of oral contraceptives. We found a statistically significant negative association between increasing age at menarche and breast-cancer risk in women born before 1925 but not after. Length of the menstrual cycle at age 30 seemed to be adversely related to breast-cancer risk, with OR for women with cycle lengths < 24 days and > 30 days being 0.76 and 1.18, as compared with women with a cycle length of 28 days. There was a strong trend of decreasing breast-cancer risk with increasing parity (OR per borne child 0.85, 95% CI 0.80-0.90). Lactation, menopausal symptoms or past use of oral contraceptives did not appear associated with breast-cancer risk. Our findings provide some evidence of a role of environmental correlates of early menarche in breast-cancer aetiology, and underline the importance of childbirth, especially early in life, in the prevention of breast cancer. Our data are not readily compatible with an important influence of former oral contraceptive use on post-menopausal breast-cancer risk.

Entities:  

Keywords:  Biology; Breast Cancer--etiology; Cancer; Case Control Studies; Contraception; Contraceptive Methods; Developed Countries; Diseases; Epidemiology; Europe; Family Planning; Health; Neoplasms; Northern Europe; Oral Contraceptives; Public Health; Research Methodology; Research Report; Risk Factors--women; Scandinavia; Studies; Sweden; Women

Mesh:

Substances:

Year:  1999        PMID: 9935204     DOI: 10.1002/(sici)1097-0215(19990118)80:2<231::aid-ijc11>3.0.co;2-r

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women.

Authors:  F Clavel-Chapelon
Journal:  Cancer Causes Control       Date:  2002-11       Impact factor: 2.506

2.  Impact of breastfeeding duration on age at menarche.

Authors:  Ban Al-Sahab; Linda Adair; Mazen J Hamadeh; Chris I Ardern; Hala Tamim
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

3.  Impact of menstrual and reproductive factors on breast cancer risk in Tunisia: a case-control study.

Authors:  Awatef Msolly; Olfa Gharbi; Slim Ben Ahmed
Journal:  Med Oncol       Date:  2013-02-02       Impact factor: 3.064

4.  Maternal pre-pregnancy BMI, gestational weight gain, and age at menarche in daughters.

Authors:  Julianna Deardorff; Rachel Berry-Millett; David Rehkopf; Ellen Luecke; Maureen Lahiff; Barbara Abrams
Journal:  Matern Child Health J       Date:  2013-10

Review 5.  Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis?

Authors:  F Clavel-Chapelon; M Gerber
Journal:  Breast Cancer Res Treat       Date:  2002-03       Impact factor: 4.872

Review 6.  Oral contraceptives and cancer: an update.

Authors:  C La Vecchia; A Altieri; S Franceschi; A Tavani
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

7.  Maternal body mass index and daughters' age at menarche.

Authors:  Sarah A Keim; Amy M Branum; Mark A Klebanoff; Babette S Zemel
Journal:  Epidemiology       Date:  2009-09       Impact factor: 4.822

8.  Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.

Authors:  Jingmei Li; Keith Humphreys; Louise Eriksson; Gustaf Edgren; Kamila Czene; Per Hall
Journal:  J Clin Oncol       Date:  2013-04-22       Impact factor: 44.544

9.  Breast cancer incidence and overdiagnosis in Catalonia (Spain).

Authors:  Montserrat Martinez-Alonso; Ester Vilaprinyo; Rafael Marcos-Gragera; Montserrat Rue
Journal:  Breast Cancer Res       Date:  2010-08-03       Impact factor: 6.466

Review 10.  Use of Oral Contraceptives as a Potential Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis of Case-Control Studies Up to 2010.

Authors:  Wiesław Kanadys; Agnieszka Barańska; Maria Malm; Agata Błaszczuk; Małgorzata Polz-Dacewicz; Mariola Janiszewska; Marian Jędrych
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.